Stuckey, Bronwyn_V2

Dr Bronwyn Stuckey

Clinical Endocrinologist; Consultant endocrinologist, Sir Charles Gairdner Hospital; Medical Director, Keogh Institute for Medical Research; Clinical Professor, Medical School, University of Western Australia
Bronwyn Stuckey is a clinical endocrinologist with a special interest in reproductive endocrinology. She is a consultant endocrinologist at the Sir Charles Gairdner Hospital in Perth, Western Australia, Medical Director of the Keogh Institute for Medical Research and Clinical Professor in the Medical School, University of Western Australia. She is a Past President of the Australasian Menopause Society, a Life Member of the Endocrine Society of Australia, and a Member of the Order of Australia. She is very interested in the influence of reproductive hormones on metabolism.

More from this expert

Podcasts iconPodcasts

From evolving guidance on MHT and breast cancer risk to the challenges of perimenopause and emerging non-hormonal treatments, this discussion offers practical insights navigating care in a changing landscape.

From evolving guidance on MHT and breast cancer risk to the challenges of perimenopause and emerging non-hormonal treatments, this discussion offers practical insights navigating care in a changing landscape.

Podcasts iconPodcasts

This episode breaks down the new Australian osteoporosis guidelines into clear, practical steps for healthcare professionals on clarifying diagnosis, risk assessment and real-world treatment decisions.

Podcasts iconPodcasts

In today’s episode, Prof Bronwyn Stuckey answers questions on applying updated osteoporosis guidance to real-world general practice decisions across assessment, treatment choice and long-term monitoring.

Podcasts iconPodcasts

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.